New Breakthrough in Research Helps to Treat Obesity and Other Related Conditions

Researchers at the Albert Einstein College of Medicine of Yeshiva University have identified how fat is stored in cells.

In discovering the genes responsible for storing fat, researchers have answered one of the most fundamental questions in biology and is bound to lead to new strategies to treat obesity and many other conditions, such as heart disease and diabetes, where fat metabolism goes awry.

Researchers had previously identified the genes responsible for making fat within cells. However, the genes governing the next step--packaging the fat inside a layer of phospholipids and proteins to form lipid droplets—have long been sought.

“Storing fat in lipid droplets appears crucially important for enabling cells to use fat as an energy source. From yeast to humans, partitioning fat into droplets is a universal feature among animals. And in humans, of course, acquiring excessive amounts of these fat droplets in our fat tissue leads to obesity,” Dr. David Silver, assistant professor of biochemistry at Einstein and senior author of the study, said.

The research team identified two genes that are crucial for packaging fat into lipid droplets. They called the genes FIT1 and FIT2 (for Fat-Inducing Transcripts 1 and 2).

Both genes code for proteins that are more than 200 amino acids in length, and the two genes are 50 percent similar to each other. The amino acid sequences of the FIT proteins do not resemble any other known proteins found in any species, indicating that the FIT genes comprise a novel gene family.

To confirm the roles of FIT1 and FIT2 in fat storage, the team conducted several different experiments. In one experiment, they over expressed both FIT1 and FIT2 genes (i.e., inserted extra copies of them) in human cells. While the rate of fat synthesis stayed the same in both ‘overexpressed’ and control cells, the number of lipid droplets in the ‘overexpressed’ cells increased dramatically, between four- and six-fold.

Using a different tactic to evaluate FIT function, the researchers next ‘knocked down’ FIT2 in mouse fat cells (FIT1 is not expressed in these cells). Their reasoning: If FIT2 is indeed essential for lipid droplet formation, then suppressing FIT2 expression should abolish lipid-droplet accumulation. Examination of these fat cells for lipid droplets revealed that cells with suppressed FIT2 expression had a drastic reduction in lipid droplets.

Finally, the team carried out a similar FIT2 ‘knock down’ experiment in a whole animal—the zebrafish. Zebrafish eggs were injected with a segment of DNA designed to interfere with FIT2 expression.

Then, to induce lipid droplet formation in zebrafish larvae (where it is localized mainly in the liver and intestine), free-swimming six-day-old larvae were fed a high-fat diet for six hours. Although the larvae had exhibited normal feeding behavior, examination of their livers and intestines revealed a near-absence of lipid droplets.

“These lines of evidence supported our conclusion that FIT genes are necessary for the accumulation of lipid droplets in cells. Now that we’ve identified the genes and the proteins they code for, it should be possible to develop drugs that can regulate their expression or activity. Such drugs could prove extremely valuable, not only for treating the main result of excess lipid droplet accumulation—obesity--but for alleviating the serious disorders that arise from obesity including type 2 diabetes and heart disease,” Dr. Silver.

Their findings appear online in the issue of the Proceedings of the National Academy of Sciences.

Source-ANI
LIN/P